Patents by Inventor Andrew H. Cragg

Andrew H. Cragg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150190257
    Abstract: Stent graft delivery systems are disclosed herein. In several embodiments, a stent graft delivery system can include a stent graft having a proximal portion and a distal portion, a proximal sheath and a distal sheath. The proximal sheath can be configured to cover the proximal portion of the stent graft, and the distal sheath can be configured to cover the distal portion of the stent graft. The proximal sheath and the distal sheath can be independently removable from respective ends of the stent graft such that the proximal and distal portions of the stent graft are independently deployable.
    Type: Application
    Filed: September 26, 2014
    Publication date: July 9, 2015
    Inventors: Andrew H. Cragg, Isa Rizk, Stephen Sosnowski, John Logan, Mahmood Dehdashtian, Pedram Nourian
  • Publication number: 20150057538
    Abstract: Disclosed are methods and devices for monitoring total delivered dose of an analyte of interest, such as an iodine containing contrast media used during intravascular procedures. The device includes a flow rate measuring capability, and an analyte concentration measuring capability. Total cumulative delivered dose of the analyte can be determined, without regard to the number of sources of analyte and variations in concentration of the analyte delivered over the course of an intravascular procedure.
    Type: Application
    Filed: August 22, 2014
    Publication date: February 26, 2015
    Inventors: Andrew H. Cragg, Gerard Von Hoffmann
  • Publication number: 20150039018
    Abstract: The present disclosure describes an occlusion device and methods of delivering the occlusion device. The occlusion device can include an expandable structure configured to move between an unexpanded configuration and an expanded configuration. The expandable structure can be configured to have an expansion ratio of at least about 5:1. Further, the occlusion device can be configured to prevent substantially all fluid from flowing past the occlusion device when the occlusion device is in the expanded configuration in the vessel.
    Type: Application
    Filed: October 17, 2014
    Publication date: February 5, 2015
    Inventors: Andrew H. Cragg, John Logan, Brett E. Naglreiter, Scott R. Arp, Alejandro Espinosa, Nicholas A. Green, Victor M. Gamez
  • Publication number: 20150039019
    Abstract: The present disclosure describes an occlusion device and methods of delivering the occlusion device. The occlusion device can include an expandable structure configured to move between an unexpanded configuration and an expanded configuration. The expandable structure can be configured to have an expansion ratio of at least about 5:1. Further, the occlusion device can be configured to prevent substantially all fluid from flowing past the occlusion device when the occlusion device is in the expanded configuration in the vessel.
    Type: Application
    Filed: October 17, 2014
    Publication date: February 5, 2015
    Inventors: Andrew H. Cragg, John Logan, Brett E. Naglreiter, Scott R. Arp, Alejandro Espinosa, Nicholas A. Green, Victor M. Gamez
  • Publication number: 20150039017
    Abstract: The present disclosure describes an occlusion device and methods of delivering the occlusion device. The occlusion device can include an expandable structure configured to move between an unexpanded configuration and an expanded configuration. The expandable structure can be configured to have an expansion ratio of at least about 5:1. Further, the occlusion device can be configured to prevent substantially all fluid from flowing past the occlusion device when the occlusion device is in the expanded configuration in the vessel.
    Type: Application
    Filed: July 31, 2014
    Publication date: February 5, 2015
    Inventors: Andrew H. Cragg, John Logan, Brett E. Naglreiter, Scott R. Arp, Alejandro Espinosa, Nicholas A. Green, Victor M. Gamez
  • Publication number: 20150039020
    Abstract: The present disclosure describes an occlusion device and methods of delivering the occlusion device. The occlusion device can include an expandable structure configured to move between an unexpanded configuration and an expanded configuration. The expandable structure can be configured to have an expansion ratio of at least about 5:1. Further, the occlusion device can be configured to prevent substantially all fluid from flowing past the occlusion device when the occlusion device is in the expanded configuration in the vessel.
    Type: Application
    Filed: October 17, 2014
    Publication date: February 5, 2015
    Inventors: Andrew H. Cragg, John Logan, Brett E. Naglreiter, Scott R. Arp, Alejandro Espinosa, Nicholas A. Green, Victor M. Gamez
  • Patent number: 8945172
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Grant
    Filed: December 30, 2011
    Date of Patent: February 3, 2015
    Assignee: Covidien LP
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Patent number: 8945143
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: February 3, 2015
    Assignee: Covidien LP
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Patent number: 8858613
    Abstract: Stent graft delivery systems are disclosed herein. In several embodiments, a stent graft delivery system can include a stent graft having a proximal portion and a distal portion, a proximal sheath and a distal sheath. The proximal sheath can be configured to cover the proximal portion of the stent graft, and the distal sheath can be configured to cover the distal portion of the stent graft. The proximal sheath and the distal sheath can be independently removable from respective ends of the stent graft such that the proximal and distal portions of the stent graft are independently deployable.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: October 14, 2014
    Assignee: Altura Medical, Inc.
    Inventors: Andrew H. Cragg, Isa Rizk, Stephen Sosnowski, John Logan, Mahmood Dehdashtian, Pedram Nourian
  • Publication number: 20140277367
    Abstract: Modular endograft devices and associated systems and methods are disclosed herein. In several embodiments, an endograft system can include constrained first and second endograft devices that extend across a vascular defect and expanded to press mating septal walls against each other. At least one of the endograft devices can include a fenestration that is aligned with a renal artery to provide bloodflow to the artery. A delivery device configured in accordance with the present technology can include a guidewire that passes through the fenestration to guide the endograft to an implant site and self align the fenestration with the renal artery to facilitate connection of the endograft to the renal artery. An additional stent can be connected to the fenestration to secure the renal artery to the endograft device.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: Altura Medical, Inc.
    Inventors: Andrew H. Cragg, John Logan
  • Publication number: 20140246025
    Abstract: A device for treating a patient suffering from obstructive sleep apnea or snoring can include an expiratory valve connected to a manifold. The expiratory valve can include a body portion including a feedback port configured to be connected to an air flow generator. The expiratory valve can include a plunger at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber positioned between an end of the plunger and an end of the expiratory valve. The pressurizing chamber can be configured to receive air from the air flow generator through the feedback port.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Fresca Medical, Inc.
    Inventors: Andrew H. Cragg, John Logan, Haim Nissimov, Richard Ewers, Mark Adler, Eugene G. Chen, John Edwin Trusheim, John Nolting, Steve Anderson, Kevin Chen
  • Publication number: 20140246024
    Abstract: A device for treating a patient suffering from obstructive sleep apnea or snoring can include an expiratory valve connected to a manifold. The expiratory valve can include a body portion including a feedback port configured to be connected to an air flow generator. The expiratory valve can include a plunger at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber positioned between an end of the plunger and an end of the expiratory valve. The pressurizing chamber can be configured to receive air from the air flow generator through the feedback port.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Fresca Medical, Inc.
    Inventors: Andrew H. Cragg, John Logan, Haim Nissimov, Richard Ewers, Mark Adler, Eugene G. Chen, John Edwin Trusheim, John Nolting, Steve Anderson, Kevin Chen
  • Publication number: 20140155981
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Application
    Filed: June 24, 2013
    Publication date: June 5, 2014
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Publication number: 20140121758
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can comprise a three-step progressive treatment process that includes immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis and maceration. The progressive, or modular, treatment can be provided by a system or kit of one or more treatment devices.
    Type: Application
    Filed: October 15, 2013
    Publication date: May 1, 2014
    Applicant: COVIDIEN LP
    Inventors: David A. FERRERA, Andrew H. CRAGG, John FULKERSON
  • Patent number: 8709087
    Abstract: Methods for correcting a deformity in the spine by forming a trans-sacral axial instrumentation/fusion axial bore through vertebral bodies in general alignment with a visualized, anterior axial instrumentation/fusion line in a minimally invasive, low trauma, manner and providing a therapy to the spine employing the axial bore. Curved or relatively straight anterior axial bores are formed from the anterior starting positions. The therapies performed through the axial bores include discoscopy, full and partial discectomy, vertebroplasty, balloon-assisted vertebroplasty, drug delivery, electrical stimulation and various forms of spinal disc cavity augmentation, spinal disc replacement, fusion of spinal motion segments and implantation of radioactive seeds. Axial spinal implants and bone growth materials can be placed into single or multiple parallel or diverging axial bores to fuse two or more vertebrae, or distract or shock absorb two or more vertebrae.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: April 29, 2014
    Assignee: Baxano Surgical, Inc.
    Inventor: Andrew H. Cragg
  • Patent number: 8709067
    Abstract: The present invention provides, in a first aspect a bifurcated stent for use in juxtaposition with an angelogical bifurcation. The bifurcated stent comprises a proximal portion adapted to be disposed within a blood vessel in juxtaposition with a bifurcation, a first distal stent portion adapted to extend across the bifurcation into one of the branched blood vessels, and a second distal stent portion adapted to allow blood to flow from the proximal portion into the other branch blood vessel. The invention also embraces a bifurcated prosthesis including such a bifurcated stent and a tubular graft layer formed from a biocompatible fabric in juxtaposition with the stent. In a second aspect of the invention there is provided a stent connection for joining two stents one to the other to define a continuous lumen through the two stents. Said stent connection comprises a first stent including a male engaging portion which can be compressed radially inwardly and a second stent including a female cooperating portion.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: April 29, 2014
    Assignee: Lifeshield Sciences, LLC
    Inventors: Andrew H. Cragg, Claude Mialhe, George Goicoechea, John Hudson, Michael D. Dake
  • Patent number: 8696702
    Abstract: A method of facilitating hemostasis of a blood vessel puncture. The method includes the steps of inserting a tubular device into a puncture in a blood vessel to establish access to the blood vessel, providing a vessel closure system around the tubular device, introducing a hemostatic material into a space between the tubular device and vessel closure system, and delivering the hemostatic material adjacent to the puncture to facilitate hemostasis of the puncture.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: April 15, 2014
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Andrew H. Cragg, Mark Ashby
  • Publication number: 20140052232
    Abstract: Handle assemblies for stent graft delivery systems and associated methods are disclosed herein. In several embodiments, a handle assembly for a stent graft delivery system includes a movable pushing component configured to deliver a distal portion of the stent graft to an arterial target site. The assembly further includes a moveable pulling component configured to interface with the pushing component and provide a compression force to the distal portion of the stent graft. The stent graft comprises a helix angle and the pulling component is configured to move relative to the pushing component at a ratio corresponding to the helix angle.
    Type: Application
    Filed: August 9, 2013
    Publication date: February 20, 2014
    Inventors: Andrew H. Cragg, John Logan, George Tsai, Nelson Quintana, Mahmood Dehdashtian
  • Publication number: 20140046428
    Abstract: Stent delivery systems and associated methods for delivering stents are disclosed herein. In several embodiments, a handle assembly for delivering a stent from a tubular enclosure can include a first lead screw having a first lead thread of a first pitch and first handedness, a second lead screw having a second lead thread of a second pitch and second handedness different from the first handedness, and a housing defining threads of the first and second pitches. The first lead screw can be in mechanical communication with the tubular enclosure, and the second lead screw can be in mechanical communication with the stent. Upon rotation of a portion of the housing, the housing threads can engage the lead screws so as to induce simultaneous translations of the lead screws in opposite directions. The simultaneous translations are configured to deploy the stent from the tubular enclosure.
    Type: Application
    Filed: August 9, 2013
    Publication date: February 13, 2014
    Inventors: Andrew H. Cragg, John Logan, Nelson Quintana, Mahmood Dehdashtian, George Tsai
  • Publication number: 20140046429
    Abstract: Stent delivery systems and associated methods for delivering stents are disclosed herein. In several embodiments, a handle assembly for delivering a stent from a tubular enclosure can include a first lead screw having a first lead thread of a first pitch and first handedness, a second lead screw having a second lead thread of a second pitch and second handedness different from the first handedness, and a housing defining threads of the first and second pitches. The first lead screw can be in mechanical communication with the tubular enclosure, and the second lead screw can be in mechanical communication with the stent. Upon rotation of a portion of the housing, the housing threads can engage the lead screws so as to induce simultaneous translations of the lead screws in opposite directions. The simultaneous translations are configured to deploy the stent from the tubular enclosure.
    Type: Application
    Filed: August 9, 2013
    Publication date: February 13, 2014
    Applicant: ALTURA MEDICAL, INC.
    Inventors: Andrew H. Cragg, John Logan, George Tsai, Nelson Quintana, Mahmood Dehdashtian